Kiropraktisk Klinik MLV ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.6% 2.9% 2.4% 2.4% 2.5%  
Credit score (0-100)  63 58 62 63 62  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  1,452 820 940 1,083 1,169  
EBITDA  982 452 536 598 664  
EBIT  680 152 236 299 365  
Pre-tax profit (PTP)  534.9 23.0 118.3 189.4 247.4  
Net earnings  344.6 12.7 87.1 142.2 186.8  
Pre-tax profit without non-rec. items  535 23.0 118 189 247  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  896 843 790 737 685  
Shareholders equity total  449 407 454 516 585  
Interest-bearing liabilities  2,417 2,188 1,816 1,596 1,212  
Balance sheet total (assets)  3,865 3,416 3,222 2,904 2,562  

Net Debt  2,417 2,188 1,816 1,596 1,212  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,452 820 940 1,083 1,169  
Gross profit growth  0.0% -43.5% 14.6% 15.2% 7.9%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,865 3,416 3,222 2,904 2,562  
Balance sheet change%  0.0% -11.6% -5.7% -9.9% -11.8%  
Added value  982.3 452.4 535.5 598.4 664.4  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  2,814 -600 -600 -600 -599  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 4.0 5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  46.8% 18.6% 25.1% 27.6% 31.2%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.6% 4.2% 7.1% 9.7% 13.3%  
ROI %  18.8% 4.4% 7.7% 10.8% 14.8%  
ROE %  76.7% 3.0% 20.2% 29.3% 33.9%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  11.6% 11.9% 14.1% 17.8% 22.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  246.0% 483.5% 339.0% 266.7% 182.4%  
Gearing %  538.1% 537.2% 399.9% 309.1% 207.0%  
Net interest  0 0 0 0 0  
Financing costs %  12.0% 5.6% 5.9% 6.4% 8.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.1 0.2 0.2 0.1 0.0  
Current Ratio  0.1 0.2 0.2 0.1 0.0  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -2,292.7 -1,960.0 -1,725.9 -1,630.3 -1,496.6  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  982 452 536 598 664  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  982 452 536 598 664  
EBIT / employee  680 152 236 299 365  
Net earnings / employee  345 13 87 142 187